McGraw-Hill's 2018/2019 Top 300 Pharmacy Drug Cards | 4 Edition

Details about McGraw-Hill's 2018/2019 Top 300 Pharmacy Drug Cards:

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. A fast, fun, and effective way to learn essential information about the top 300 drugs Includes audio Q&A with detailed discussion for each drug at Top300DrugCards.com and 15 BONUS CARDS ON VACCINES! Everything you need to know about the top 300 drugs in one easy-to-carry resource. Each card includes: • Generic and common name • Class • Dosage Forms • Approved Dose and Indications • Off-Label Use • Contraindications • Adverse Reactions • Drug Interactions • Monitoring Parameters • Medication Safety Issues and Black Box Warnings • Strong focus on patient safety Great for NAPLEX® and course review! Send feedback to the editors: Jill M. Kolesar, PharmD, MS, BCPS, FCCP, Professor, College of Pharmacy, Director, Early Phase Clinical Trials Center, Co-Director, Molecular Tumor Board, Markey Cancer Center, University of Kentucky. Email: jill.kolesar@uky.edu Lee Vermeulen, BSPharm, MS, FCCP, FFIP, Chief, Academic Service Lines, UK HealthCare and Professor of Medicine and Pharmacy, University of Kentucky. Email: Lee.Vermeulen@uky.edu